The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We're seeing a lot of doctors get a lot more comfortable with the idea of prescribing Metformin off-label. Just a few years ago, you know, the constraints of what Metformin was actually approved for was keeping it out of the hands of a lot of people who thought that it might be good for them in their efforts to slow their aging.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And part of it is education. Typically when a doctor sees the evidence and there's extensive literature, and sometimes it's the patient takes the information to the doctor or our book. The doctor in most cases is convinced that this is worth the risk.